Last reviewed · How we verify

NCT03870958: MIHMex

Glass Ionomer Cement Sealant in the Prevention of Post-eruptive Fractures in Molars Affected by MIH

Status unknown NA Last updated 16 September 2020
What this trial tests

NA trial testing GIC sealant (GC Fuji TRIAGE®) in Molar Incisor Hypomineralization in 195 participants. Status unknown.

Timeline
20 November 2018
Primary endpoint
20 December 2019
20 December 2021

Quick facts

Lead sponsorIsabel Cristina Olegário da Costa
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment195
Start date20 November 2018
Primary completion20 December 2019
Estimated completion20 December 2021
Sites1 location across Mexico

Drugs / interventions tested

Conditions studied

Sponsor

Isabel Cristina Olegário da Costa

Who can join

Adults 6 to 9, any sex, with Molar Incisor Hypomineralization. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This trial will compare the application of Glass Ionomer Cement (GIC) sealant with no-intervention for the most clinically- and cost-effective strategy for managing MIH molars without post-eruptive breakdown, in a school setting, using low-technology and child-friendly dental techniques. Methods/Design: This two-arm, parallel group, patient-randomized controlled, superiority trial will have treatment provided in schools. Schoolchildren (age 6-9), presenting at least one MIH molar (n molars = 195,) will have random allocation to treatment with or without the application of a GIC sealant (GC Fuji TRIAGE®, GC Europe, Leuven, Belgium). Baseline measures and outcome data will be assessed through participant report and clinical examination. The primary outcome is the presence of post-eruptive fracture and development of caries lesions. Secondary outcomes are: (1) self-reported dental hypersensitivity; (2) oral health-related-quality of life, reported by children; (3) plaque index, (4) gingival health, (5) caries status (according to ICCMS scores) in primary and permanent teeth; (6) the incremental cost-effectiveness. A trained and calibrated examiner will evaluate the treated teeth every six months post treatment for a period of 36 months. Kaplan-Meier and Cox regression tests will be used to investigate the primary outcome. The Logistic Regression and Poisson Regression Analysis will be used to analyze the secondary outcomes (α=5%).

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Glass Ionomer Sealants Can Prevent Dental Caries but Cannot Prevent Posteruptive Breakdown on Molars Affected by Molar Incisor Hypomineralization: One-Year Results of a Randomized Clinical Trial.
    Schraverus MS, Olegário IC, Bonifácio CC, González APR, et al · · 2021 · cited 13× · PMID 34107492 · DOI 10.1159/000516266
  2. Outcome and comparator choice in molar incisor hypomineralisation (MIH) intervention studies: a systematic review and social network analysis.
    Elhennawy K, Krois J, Jost-Brinkmann PG, Schwendicke F. · · 2019 · cited 7× · PMID 31377700 · DOI 10.1136/bmjopen-2018-028352

Verify or expand the search:

Other recruiting trials for Molar Incisor Hypomineralization

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03870958.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing